Trials with rafoxanide. 5. Efficacy studies against Fasciola hepatica, Fasciola gigantica, Paramphistomum microbothrium and various nematodes in sheep.
D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D005209:Fasciola; D005210:Fasciola hepatica; D005211:Fascioliasis / Q000662:veterinary*; D005260:Female; D006725:Hookworm Infections / Q000188:drug therapy / Q000662:veterinary; D007455:Iodine / Q000008:administration & dosage / Q000627:therapeutic use; D009349:Nematode Infections / Q000662:veterinary*; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D012457:Salicylamides / Q000008:administration & dosage / Q000627:therapeutic use*; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy*; D013320:Strongyloidea; D014201:Trematode Infections / Q000188:drug therapy / Q000662:veterinary*; D014252:Trichostrongyloidiasis / Q000188:drug therapy / Q000662:veterinary
D000871:Anthelmintics; D010647:Phenyl Ethers; D012457:Salicylamides; D007455:Iodine